ACCENDRA HEALTH INC/VA/ Leases Disclosure
Note 6—Leases
The components of lease expense were as follows:
| | Years Ended December 31, | |||||||||
| Classification | | 2025 | | 2024 |
| 2023 | ||||
Operating lease cost | SG&A expenses | $ | 52,333 | $ | 53,283 | $ | 47,090 | ||||
Short-term lease cost | SG&A expenses, Cost of net revenue |
| 6,475 |
| 10,203 |
| 7,106 | ||||
Variable lease cost | SG&A expenses, Cost of net revenue |
| 24,746 |
| 25,024 |
| 24,368 | ||||
Total lease cost | $ | 83,554 | $ | 88,510 | $ | 78,564 | |||||
Variable lease cost consists primarily of taxes, insurance, and common area or other maintenance costs for our leased facilities and patient service equipment which are paid as incurred.
Supplemental balance sheet information was as follows:
| | As of December 31, | As of December 31, | |||||
| Classification | | 2025 | | 2024 | |||
Assets: | | |
| | ||||
Operating lease assets | Operating lease assets | $ | 109,099 | $ | 126,928 | |||
Liabilities: | |
|
| |||||
Current operating leases | $ | 43,272 | $ | 41,217 | ||||
Noncurrent operating leases | Operating lease liabilities, excluding current portion |
| 70,317 |
| 89,466 | |||
Total operating lease liabilities | $ | 113,589 | $ | 130,683 | ||||
Other information related to leases was as follows:
| Years Ended December 31, | |||||||||||
| 2025 | 2024 | 2023 | |||||||||
Supplemental cash flow information | |
| | | ||||||||
Cash paid for amounts included in the measurement of lease liabilities: | |
| | | ||||||||
Operating cash flows from operating leases | $ | 52,705 | $ | 52,606 | $ | 49,352 | ||||||
Right-of-use assets obtained in exchange for new operating lease liabilities | $ | 33,211 | $ | 40,176 | $ | 69,666 | ||||||
Weighted average remaining lease term (years) |
|
| |
| | |||||||
Operating leases |
| 3.3 |
| 3.7 |
| 4.0 | ||||||
Weighted average discount rate |
|
| |
| | |||||||
Operating leases |
| 8.0 | % |
| 6.2 | % |
| 5.8 | % | |||
Maturities of lease liabilities as of December 31, 2025 were as follows:
| |||
2026 | $ | 49,425 | |
2027 |
| 36,682 | |
2028 |
| 24,709 | |
2029 |
| 13,396 | |
2030 |
| 6,423 | |
Thereafter |
| 2,207 | |
Total lease payments |
| 132,842 | |
Less: Interest |
| (19,253) | |
Present value of lease liabilities | $ | 113,589 | |
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 20, 2026 | Showing above |
| 2024 | Feb 28, 2025 | |
| 2023 | Feb 20, 2024 | |
| 2022 | Feb 28, 2023 | |
| 2021 | Feb 23, 2022 | |
| 2020 | Feb 24, 2021 | |
| 2019 | Mar 4, 2020 | |
About Leases Disclosures
Lease disclosures under ASC 842 provide a comprehensive view of a company's leased asset portfolio, including the split between operating and finance leases, discount rates used to present-value future payments, and the maturity schedule of lease obligations. This section reveals a significant source of off-balance-sheet commitments that were largely hidden before the current standard.
Key signals: the weighted-average discount rate affects the size of recorded lease liabilities — a higher rate reduces the reported obligation, so compare the chosen rate against the company's incremental borrowing rate. The operating versus finance lease mix affects both EBITDA and operating income presentation. Watch the maturity table for concentration risk: large payment cliffs in specific years may create cash flow pressure. Variable lease payments excluded from the liability measurement represent real obligations that do not appear on the balance sheet. Compare total lease costs against prior-year operating lease expense to assess the true economic burden.